Posted 1 year ago by Wales Gene Park

This trial is looking at a new treatment using anti-GD2 T-cells. The researchers are taking immune cells from the blood and changing them so they can attack the cancer cells. Cancer Research UK is supporting this trial. The aims of the trial are to find out: if they can make anti-GD2 T-cells in the laboratory and if it is safe to give to people about any side effects and the best way to treat them whether giving chemotherapy first, improves how long the anti-GD2 T-cells survive and helps to increase their number how well and for how long the anti-GD2 T-cells survive inside the body whether anti-GD2 T-cells can shrink the neuroblastoma

 Neuroblastoma /  London

No post found